FI106200B - Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten valmistamiseksi Download PDFInfo
- Publication number
- FI106200B FI106200B FI943247A FI943247A FI106200B FI 106200 B FI106200 B FI 106200B FI 943247 A FI943247 A FI 943247A FI 943247 A FI943247 A FI 943247A FI 106200 B FI106200 B FI 106200B
- Authority
- FI
- Finland
- Prior art keywords
- pct
- formula
- compounds
- process according
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929200293A GB9200293D0 (en) | 1992-01-08 | 1992-01-08 | Piperazine derivatives |
GB9200293 | 1992-01-08 | ||
PCT/GB1992/002399 WO1993014076A1 (en) | 1992-01-08 | 1992-12-24 | Piperazine derivatives as 5-ht receptors antagonists |
GB9202399 | 1992-12-24 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI943247A0 FI943247A0 (fi) | 1994-07-07 |
FI943247A FI943247A (fi) | 1994-07-07 |
FI106200B true FI106200B (fi) | 2000-12-15 |
Family
ID=10708249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI943247A FI106200B (fi) | 1992-01-08 | 1994-07-07 | Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten valmistamiseksi |
Country Status (21)
Country | Link |
---|---|
US (1) | US5532242A (de) |
EP (1) | EP0620817B1 (de) |
JP (1) | JP3274865B2 (de) |
KR (1) | KR100283345B1 (de) |
AT (1) | ATE183504T1 (de) |
AU (1) | AU668901B2 (de) |
BR (1) | BR9207030A (de) |
CA (1) | CA2125182A1 (de) |
DE (1) | DE69229834T2 (de) |
ES (1) | ES2134835T3 (de) |
FI (1) | FI106200B (de) |
GB (2) | GB9200293D0 (de) |
HU (1) | HUT70513A (de) |
IL (1) | IL104305A (de) |
MX (1) | MX9300031A (de) |
NZ (1) | NZ246205A (de) |
PH (1) | PH30268A (de) |
RU (1) | RU2128653C1 (de) |
TW (1) | TW265337B (de) |
WO (1) | WO1993014076A1 (de) |
ZA (1) | ZA93141B (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG63579A1 (en) * | 1992-12-21 | 1999-03-30 | Smithkline Beecham Corp | Bicyclic fibrinogen antagonists |
US5609849A (en) * | 1994-03-11 | 1997-03-11 | The Trustees Of The University Of Pennsylvania | Serotonin (5-HT1A) receptor ligands and imaging agents |
US5451584A (en) * | 1994-11-10 | 1995-09-19 | American Home Products Corporation | N-alkynyl carboxamides as sertonergic agents |
US5541179A (en) * | 1995-05-02 | 1996-07-30 | American Home Products Corporation | Tropon-2-one piperazine carboxamides as serotonergic agents |
CZ315098A3 (cs) | 1996-04-05 | 1999-04-14 | Société De Conseils De Recherches Et D'applications Scientifiques (S. C. R. A. S.) | Antagonisté alfa1-adrenergických receptorů |
US5610164A (en) * | 1996-07-24 | 1997-03-11 | American Home Products Corporation | (Thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides |
US6399614B1 (en) | 1997-08-01 | 2002-06-04 | Recordati S.A. Chemical And Pharmaceutical Company | 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring |
IT1293804B1 (it) | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Diarilalchilpiperazine attive sulle basse vie urinarie |
IT1293807B1 (it) * | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico |
BR9916263A (pt) * | 1998-12-17 | 2001-09-04 | American Home Prod | Derivados de piperazina etilamida com atividade sobre receptor de 5-ht1a |
US6344458B1 (en) | 1998-12-17 | 2002-02-05 | American Home Products Corporation | Piperazine ethylamide derivatives |
EP1274444B1 (de) | 2000-03-16 | 2013-05-15 | THE McLEAN HOSPITAL CORPORATION | Cdp-cholin und uridin zur behandlung von alkoholmissbrauch |
PL360286A1 (en) | 2000-06-27 | 2004-09-06 | Taisho Pharmaceutical Co.Ltd. | Remedial agent for anxiety neurosis or depression and piperazine derivative |
WO2005122767A1 (en) | 2004-06-10 | 2005-12-29 | Mclean Hospital Corporation | Pyrimidines, such as uridine, in treatments for patients with bipolar disorder |
US7947661B2 (en) | 2004-08-11 | 2011-05-24 | The Mclean Hospital Corporation | Compounds for the treatment of marihuana dependence, withdrawal, and usage |
US7731940B2 (en) | 2006-01-25 | 2010-06-08 | The Regents Of The University Of California | Compositions and methods related to serotonin 5-HT1A receptors |
TWI417095B (zh) * | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途 |
TW200845978A (en) * | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
UA100126C2 (en) | 2007-09-14 | 2012-11-26 | Аддекс Фарма С.А. | 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones |
JP5433579B2 (ja) * | 2007-09-14 | 2014-03-05 | ジャンセン ファーマシューティカルズ, インコーポレイテッド. | 1,3−二置換−4−フェニル−1h−ピリジン−2−オン |
PT2200985E (pt) | 2007-09-14 | 2011-07-21 | Ortho Mcneil Janssen Pharm | 4-(aril-x-fenil)-1h-piridin-2-onas 1,3-dissubstituídas |
CN101861316B (zh) * | 2007-11-14 | 2013-08-21 | 奥梅-杨森制药有限公司 | 咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途 |
AU2009289784B2 (en) | 2008-09-02 | 2012-03-22 | Addex Pharma S.A. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
RU2517181C2 (ru) | 2008-10-16 | 2014-05-27 | Орто-Макнейл-Янссен Фармасьютикалз, Инк. | Производные индола и бензоморфолина в качестве модулятора метаботропных глутаматных рецепторов |
BRPI0921333A2 (pt) | 2008-11-28 | 2015-12-29 | Addex Pharmaceuticals Sa | derivados de indol e benzoxazina como moduladores de receptores de glutamato metabotrópicos |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
BRPI1010831A2 (pt) | 2009-05-12 | 2016-04-05 | Addex Pharmaceuticals Sa | derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2 |
KR101753826B1 (ko) | 2009-05-12 | 2017-07-04 | 얀센 파마슈티칼즈, 인코포레이티드 | 1,2,4―트리아졸로[4,3―a]피리딘 유도체 및 신경정신 질환의 치료 또는 예방을 위한 이들의 용도 |
WO2011027656A1 (en) | 2009-09-04 | 2011-03-10 | Semiconductor Energy Laboratory Co., Ltd. | Transistor and display device |
ES2536433T3 (es) | 2010-11-08 | 2015-05-25 | Janssen Pharmaceuticals, Inc. | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2 |
AU2011328203B2 (en) | 2010-11-08 | 2015-03-19 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
EP2649069B1 (de) | 2010-11-08 | 2015-08-26 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazol[4,3-a]pyridinderivate und ihre verwendung als positive allosterische mglur2-rezeptormodulatoren |
CN103360342B (zh) * | 2012-04-09 | 2015-12-16 | 江苏恩华药业股份有限公司 | 3-氰基苯胺烷基芳基哌嗪衍生物及在制备药物中的应用 |
JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
HUE045610T2 (hu) | 2014-01-21 | 2020-01-28 | Janssen Pharmaceutica Nv | 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait vagy ortosztérikus agonistáit tartalmazó kombinációk és alkalmazásuk |
MX2016009471A (es) | 2014-01-21 | 2016-10-13 | Janssen Pharmaceutica Nv | Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso. |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3037982A (en) * | 1959-08-12 | 1962-06-05 | Miles Lab | Phenylpiperazinylalkyl propionanilides |
AU532411B2 (en) * | 1979-03-01 | 1983-09-29 | Duphar International Research B.V. | Phenyl piperazine derivatives |
NL8005133A (nl) * | 1980-09-12 | 1982-04-01 | Duphar Int Res | Fenylpiperazinederivaten met antiagressieve werking. |
NL8005131A (nl) * | 1980-09-12 | 1982-04-01 | Duphar Int Res | Fenylpiperazinederivaten met analgetische werking. |
EP0190472B1 (de) * | 1984-12-21 | 1989-07-12 | Duphar International Research B.V | Arzneimittel mit antipsychotischer Wirkung |
IL90279A (en) * | 1988-05-24 | 1995-03-30 | American Home Prod | History of piperazinyl carboxamide, their preparation and the pharmaceutical preparations containing them |
US5010078A (en) * | 1988-05-24 | 1991-04-23 | American Home Products Corporation | Aryl- and heteroaryl piperazinyl carboxamides having central nervous system activity |
GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
US5340812A (en) * | 1989-04-22 | 1994-08-23 | John Wyeth & Brother, Limited | Piperazine derivatives |
GB2230781B (en) * | 1989-04-22 | 1993-04-28 | Wyeth John & Brother Ltd | Piperazine derivatives |
FR2655988B1 (fr) * | 1989-12-20 | 1994-05-20 | Adir Cie | Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
DK178590D0 (da) * | 1990-07-26 | 1990-07-26 | Novo Nordisk As | 1,4-disubstituerede piperaziner |
ES2027898A6 (es) * | 1991-01-24 | 1992-06-16 | Espanola Prod Quimicos | Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina. |
-
1992
- 1992-01-08 GB GB929200293A patent/GB9200293D0/en active Pending
- 1992-12-24 AU AU31697/93A patent/AU668901B2/en not_active Ceased
- 1992-12-24 WO PCT/GB1992/002399 patent/WO1993014076A1/en active IP Right Grant
- 1992-12-24 AT AT93900365T patent/ATE183504T1/de not_active IP Right Cessation
- 1992-12-24 US US08/256,330 patent/US5532242A/en not_active Expired - Lifetime
- 1992-12-24 EP EP93900365A patent/EP0620817B1/de not_active Expired - Lifetime
- 1992-12-24 BR BR9207030A patent/BR9207030A/pt not_active Application Discontinuation
- 1992-12-24 JP JP51221993A patent/JP3274865B2/ja not_active Expired - Fee Related
- 1992-12-24 KR KR1019940702344A patent/KR100283345B1/ko not_active IP Right Cessation
- 1992-12-24 HU HU9402042A patent/HUT70513A/hu not_active IP Right Cessation
- 1992-12-24 DE DE69229834T patent/DE69229834T2/de not_active Expired - Fee Related
- 1992-12-24 ES ES93900365T patent/ES2134835T3/es not_active Expired - Lifetime
- 1992-12-24 CA CA002125182A patent/CA2125182A1/en not_active Abandoned
- 1992-12-24 NZ NZ246205A patent/NZ246205A/en unknown
- 1992-12-24 RU RU94039542A patent/RU2128653C1/ru active
- 1992-12-24 GB GB9227001A patent/GB2263110B/en not_active Expired - Fee Related
-
1993
- 1993-01-05 IL IL104305A patent/IL104305A/en not_active IP Right Cessation
- 1993-01-06 TW TW082100059A patent/TW265337B/zh active
- 1993-01-07 MX MX9300031A patent/MX9300031A/es not_active IP Right Cessation
- 1993-01-07 PH PH45533A patent/PH30268A/en unknown
- 1993-01-08 ZA ZA93141A patent/ZA93141B/xx unknown
-
1994
- 1994-07-07 FI FI943247A patent/FI106200B/fi active
Also Published As
Publication number | Publication date |
---|---|
AU3169793A (en) | 1993-08-03 |
RU2128653C1 (ru) | 1999-04-10 |
IL104305A (en) | 1998-04-05 |
GB2263110A (en) | 1993-07-14 |
RU94039542A (ru) | 1996-08-10 |
FI943247A0 (fi) | 1994-07-07 |
DE69229834D1 (de) | 1999-09-23 |
DE69229834T2 (de) | 2000-01-13 |
JPH07502739A (ja) | 1995-03-23 |
GB2263110B (en) | 1995-08-09 |
US5532242A (en) | 1996-07-02 |
ZA93141B (en) | 1994-07-08 |
MX9300031A (es) | 1993-07-01 |
KR100283345B1 (ko) | 2001-03-02 |
ATE183504T1 (de) | 1999-09-15 |
JP3274865B2 (ja) | 2002-04-15 |
EP0620817A1 (de) | 1994-10-26 |
CA2125182A1 (en) | 1993-07-22 |
HU9402042D0 (en) | 1994-09-28 |
NZ246205A (en) | 1996-12-20 |
BR9207030A (pt) | 1995-12-05 |
GB9227001D0 (en) | 1993-02-17 |
PH30268A (en) | 1997-02-20 |
WO1993014076A1 (en) | 1993-07-22 |
GB9200293D0 (en) | 1992-02-26 |
ES2134835T3 (es) | 1999-10-16 |
TW265337B (de) | 1995-12-11 |
IL104305A0 (en) | 1993-05-13 |
FI943247A (fi) | 1994-07-07 |
AU668901B2 (en) | 1996-05-23 |
EP0620817B1 (de) | 1999-08-18 |
HUT70513A (en) | 1995-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI106200B (fi) | Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten valmistamiseksi | |
KR100244626B1 (ko) | 5-ht1a 길항제로서의 피페라진 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
SK280133B6 (sk) | Piperazínové deriváty, spôsob ich výroby, farmaceu | |
HU211910A9 (en) | Piperazine derivatives | |
SK281418B6 (sk) | Deriváty piperazínu, spôsob ich prípravy, medziprodukt na ich prípravu, ich použitie ako 5ht1a antagonistov a farmaceutický prípravok s ich obsahom | |
JP2007523128A (ja) | Cb1−アンタゴニスト活性を有するイミダゾリン誘導体 | |
WO1997003982A1 (en) | Piperazine derivatives and their use as 5-ht1a antagonists | |
US5585374A (en) | Amide derivatives | |
US6306859B1 (en) | N-substituted imide derivatives with serotonergic activity | |
US5629323A (en) | Amide derivatives as 5-HT1A ligands | |
SK45196A3 (en) | 4-indolylpiperazinyl derivatives | |
US5541179A (en) | Tropon-2-one piperazine carboxamides as serotonergic agents | |
US5169845A (en) | Piperazine derivatives | |
EP0687257B1 (de) | 4-amino-2-(hetero)aryl-butanamide verwenbar als 5-ht1a-antagonisten | |
JP2002538154A (ja) | セロトニン作動活性を有するn−置換イミド誘導体 | |
FI98728C (fi) | Menetelmä terapeuttisesti käyttökelpoisen 2,3,4,5,6,7-heksahydro-1-(4- 1-/4-(2-metoksifenyyli)piperatsinyyli/ -2-fenyylibutyryyli)-1H-atsepiinin tai sen farmaseuttisesti hyväksyttävän happoadditiosuolan valmis tamiseksi | |
MXPA01008842A (es) | Derivados n-substituidos de imida con actividad serotonergica | |
MXPA00000414A (en) | Novel compounds | |
SK279528B6 (sk) | Uticképrostriedky s ich obsahom |